FDA STAFF MANUAL GUIDES, VOLUME II - DELEGATIONS OF AUTHORITY
REGULATORY - ANIMAL DRUGS
ISSUANCE OF FEDERAL REGISTER DOCUMENTS PERTAINING TO THE DETERMINATION OF SAFE LEVELS, NOTICE OF NEED FOR DEVELOPMENT OF AN ANALYTICAL METHOD, NOTICE OF AVAILABILITY OF A DEVELOPED ANALYTICAL METHOD, AND PROHIBITION OF CERTAIN EXTRALABEL DRUG USE
Effective Date: 02/24/2011
1. AUTHORITY DELEGATED AND TO WHOM DELEGATED.
The Director, the Deputy Director, and the Senior Advisor for Science Policy, Center for Veterinary Medicine (CVM), are authorized to issue Federal Register documents pertaining to the determination of safe levels, notice of need for development of an analytical method, notice of availability of a developed analytical method, and prohibition of certain extra label drug use related to implementation of Section 512(a)(4) and (5) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 360b(a)(4) and (5)).
These officials may further redelegate this authority.
3. EFFECTIVE DATE.
The Commissioner of Food and Drugs approved this delegation on February 24, 2011.
|STATUS (I, R, C)||DATE APPROVED||LOCATION OF CHANGE HISTORY||CONTACT||APPROVING OFFICIAL|
|Initial||02/24/2011||N/a||CVM/OM||Commissioner of Food and Drugs|